Repono Limited Approves Unaudited Q2 FY27 and H1 Results

Repono Limited approved its unaudited financial results for Q2 FY27 and the half year ended September 30, 2026, at a Board meeting held on November 13, 2026. The approval covers standalone and consolidated financial statements and the accompanying Limited Review Report, meeting the company’s stated disclosure requirement.

What did Repono approve for Q2 FY27?

Repono Limited approved unaudited financial results for the quarter and half year ended September 30, 2026, which correspond to Q2 FY27 and the first half of FY27. The Board of Directors considered and approved the statements at its meeting on November 13, 2026.

The disclosed information says that the approval includes both standalone and consolidated results. It also includes the Limited Review Report that accompanies the unaudited statements. However, the available announcement does not provide revenue, profit, margin, expense, cash-flow, balance-sheet, or segment-wise figures from the approved Q2 FY27 and H1 FY27 results.

When did Repono schedule the meeting and close its trading window?

Repono had scheduled the Board meeting for November 13, 2026, at 12:00 PM to consider and approve the unaudited results. The prior intimation was made under Regulation 29 and other applicable provisions of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

The company also closed its trading window from the close of trading hours on October 1, 2026. The restriction applies to directors, identified employees, key managerial personnel, promoters, designated persons and their immediate relatives, according to the disclosure. The window is to remain closed until 48 hours after the declaration of the unaudited results, in line with the company’s code and SEBI’s insider-trading regulations.

What financial data has Repono disclosed so far?

Repono has confirmed the approval of the Q2 FY27 and H1 FY27 financial statements, but the supplied disclosure does not state the underlying operating or financial numbers. As a result, a comparison with an earlier period cannot be made from this announcement alone.

Investors looking to assess the quarter will need the detailed standalone and consolidated results, including revenue from operations, profit or loss, earnings per share, expenses, assets, liabilities and cash-flow information. The announcement confirms the reporting period and Board approval, but it does not quantify Repono’s Q2 or first-half performance.

The absence of detailed figures in the available text is relevant because Board-meeting notices and outcome disclosures serve different purposes. The notice set out the agenda for approval, while the stated outcome confirms that approval occurred. A fuller results filing would be needed to determine whether the company’s operations, profitability or financial position changed during the period.

Why does the Q2 FY27 filing matter to Repono investors?

The filing matters because it formally updates the market on Repono’s reporting cycle after the company’s recent BSE listing. Repono is identified in the source as a transport infrastructure company, with BSE scrip code 544463, and the approved results cover the first six months of FY27.

The source listed Repono’s BSE closing price at ₹69.00 as of October 30, 2026, up ₹0.10 or 0.15% for that session. That market data predates the November 13 Board meeting and should not be treated as a price reaction to the approved Q2 FY27 results.

For shareholders, the key immediate point is that the Board has completed its consideration of the unaudited statements within the announced timetable. The company did not mention a dividend, fund raise, acquisition, or other corporate action in the Board-meeting agenda provided in the source. Therefore, the disclosed event is focused on periodic financial reporting rather than a separate strategic decision.

How does the disclosure fit Repono’s earlier reporting record?

Repono had previously informed the exchange that its Board would consider audited standalone and consolidated financial results for the half year and financial year ended March 31, 2026, at a meeting scheduled for May 23, 2026. The current disclosure concerns the next reported half-year period, ending September 30, 2026.

This sequence reflects the standard listed-company reporting process: audited year-end results are followed by unaudited interim results subject to a limited review. The Board’s November approval and the trading-window restrictions are procedural elements intended to support timely disclosure and limit trading by designated persons while price-sensitive financial information is pending publication.

The available material does not contain management commentary, analyst views, customer responses or operational updates. It also does not provide a confirmed market reaction after the results approval. Any assessment of Repono’s valuation, earnings trend or business outlook would require the detailed financial statements and subsequent exchange disclosures.

Conclusion

Repono Limited has completed the Board approval process for its unaudited standalone and consolidated Q2 FY27 and H1 FY27 results for the period ended September 30, 2026. The announcement establishes the timing, regulatory context and scope of the approval, while leaving the underlying financial performance figures undisclosed in the supplied material.

The next item to watch is the detailed results release, including revenue, profitability, expenses, earnings per share and balance-sheet data for Q2 and H1 FY27. Investors can also monitor the reopening of the trading window 48 hours after the results declaration and any further BSE filings from Repono.